PRESIDENTIAL DIRECTIVE/NSC-15 RE CHEMICAL WARFARE

Document Type: 
Collection: 
Document Number (FOIA) /ESDN (CREST): 
CIA-RDP81-00261R000300050013-4
Release Decision: 
RIPPUB
Original Classification: 
C
Document Page Count: 
3
Document Creation Date: 
December 9, 2016
Document Release Date: 
August 18, 2000
Sequence Number: 
13
Case Number: 
Publication Date: 
August 2, 1977
Content Type: 
MF
File: 
AttachmentSize
PDF icon CIA-RDP81-00261R000300050013-4.pdf91.42 KB
Body: 
Approved For Release 2001/09['~.~-0!,'R000300050013-4 DD/A Registry 1JZ-y/ 2 AUG 19777 ry MEMORANDUM FOR: Deputy Director for Operations Deputy Director for Intelligence Deputy Director for Science and Technology Acting Deputy Director for Administration FROM: STANSFIELD TURNER Director of Central Intelligence SUBJECT: Presidential Directive/NSC-15 re Chemical Warfare 1. The responses from the various Directorates concerning the extent of their possession of lethal, highly toxic, or incapacitating chemicals have been brought to my attention. My review of the responses coincided with the most recent media exploitation of the former MKULTRA projects. 2. It is believed appropriate, therefore, to reaffirm at this time the Agency's prohibition against the testing of behavioral drugs and the acquisition or retention of certain lethal or highly toxic materials. Your guidelines in these matters are these: a. The Agency does not and will not authorize any testing of behavioral drugs on human subjects. b. The Agency will not acquire or store lethal, highly toxic, or incapacitating chemicals if they could, under any criteria, be considered chemical or bacteriological warfare agents or as a mass weapon of any type. c. You will be held to strict accountability for all dangerous substances in your possession. Proper records must be kept, which will be subject to the examination of my office or of the Office of the Inspector General at any time. 3. The Deputy to the DCI for the Intelligence Community is in the process of preparing a DCID which provides guidelines for human subject research within the Intelligence Community. It will cover those controversial areas in con- siderable detail. Until this issuance is released, you will be expected to adhere to the more general conditions set forth above. STANSFIE5p TURNER Approved For Release 2001 fi' CIk D1!-261 ROOMQ-4 CL BY 001777 Approved For Release 2001/09/01 : CIA-RDP81=00261 R000300050013-4 SUBJECT: Presidential Directive/NSC-15 re Chemical Warfare Distribution: Orig - DDO Xcy - Each additional adse 1 - DCI 1 - ADDCI 1 - ER 1 - IG DDA Distribution: 1 - D/OC 1 - C/MAS 1 - D/ODP 1 - SSA/DDA 1 - D/OF 1 - DDA/EEO 1 - D/OL 1 - DDA/CM0 1 - D/OMS 1 DDA/BS 1 - D/OP 1 - AI/DDA 1 - D/OS 1 - C/IPS 1 - D/Op 1 - C/ISAS 1 - RCB 1 -MPB 1 - RAB 1 - RRB DDA Subject - DDA Chrono Approved For Release 2001/09/01 : CIA-RDP81-00261 R000300050013-4 Approved For Release 2001/09/01 : CIA-RDP81-00261 R000300050013-4 TRANSMITTAL SLIP DATE TO: Acting Deputy Director for Administration ROOM NO. BUILDING 1^ REMARKS; -ZT Y^~ Yy 11 ,/J FROM: Director Central Intelligence ROOM NO. BUILDING EXTENSION 1 FEB 38.241 REPLACES FORM 36-$ WHICH MAY BE USED. Approved For Release 2001/09/01 : CIA-RDP81-00261 R000300050013-4